Product
Boostrix
2 clinical trials
5 indications
Indication
Bordetella pertussisIndication
PertussisIndication
VaccinationIndication
Maternal-Fetal RelationsIndication
ImmunoglobulinsClinical trial
Phase 2b Placebo-Controlled Randomized Study of BPZE1 Intranasal Pertussis Vaccine in Healthy School-Age Children to Assess Immunological Response and Safety of a Single Dose BPZE1 With/Without Coadministration of Tdap (Boostrix™)Status: Active (not recruiting), Estimated PCD: 2024-04-01
Clinical trial
Maternal Determinants of Infant Immunity to PertussisStatus: Not yet recruiting, Estimated PCD: 2024-12-01